Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Theranostics
|
June 16, 2025
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Felix L Herr, Christian Dascalescu, Ricarda Ebner, et al.
Biomedicines
|
May 28, 2022
Total Tumor Volume on <sup>18</sup>F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with <sup>225</sup>Ac-PSMA-I&T
Lena M Unterrainer, Leonie Beyer, Mathias J Zacherl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy
Conrad-Amadeus Voltin, Sarah Flossdorf, Lars Kurch, et al.
Frontiers in Oncology
|
February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATE
Ralf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Blood Cancer Journal
|
August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Michael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry
Nika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
European Urology
|
May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Madeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Theranostics
|
June 16, 2025
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Felix L Herr, Christian Dascalescu, Ricarda Ebner, et al.
Biomedicines
|
May 28, 2022
Total Tumor Volume on <sup>18</sup>F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with <sup>225</sup>Ac-PSMA-I&T
Lena M Unterrainer, Leonie Beyer, Mathias J Zacherl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy
Conrad-Amadeus Voltin, Sarah Flossdorf, Lars Kurch, et al.
Frontiers in Oncology
|
February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATE
Ralf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Blood Cancer Journal
|
August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Michael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry
Nika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
European Urology
|
May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Madeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Page
of 6